Selected research
Market Analysis & Forecast
Global Organ Tumor Chip Market Analysis and Forecast 2026-2032
Market perspective
The global Organ Tumor Chip market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Organ Tumor Chip's global sales reached XX (k units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Axosim Technologies as the global sales leader, a title it has maintained for several consecutive years. Notably, Axosim Technologies's performance in primary markets is also remarkable. In the Chinese market, sales were XX (k units), a change of XX% from the previous year. In Europe, sales were XX (k units), showing a year-on-year of XX%. In the US, sales were XX (k units), a year-on-year change of XX%.
The major global manufacturers in the Organ Tumor Chip market include Axosim Technologies, Beonchip, BioIVT, Emulate, InSphero AG, Mimetas, Nortis and Organovo Holdings, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Organ Tumor Chip production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Organ Tumor Chip by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Organ Tumor Chip, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Organ Tumor Chip, also provides the consumption of main regions and countries. Of the upcoming market potential for Organ Tumor Chip, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Organ Tumor Chip sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Organ Tumor Chip market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Organ Tumor Chip sales, projected growth trends, production technology, application and end-user industry.
Organ Tumor Chip Segment by Company
Axosim Technologies
Beonchip
BioIVT
Emulate
InSphero AG
Mimetas
Nortis
Organovo Holdings
Organ Tumor Chip Segment by Type
Lung Tumor-on-a-chip
Bone Marrow Tumor-on-a-chip
Brain Tumor-on-a-chip
Breast Tumor-on-a-chip
Urinary System Tumor-on-a-chip
Intestine Tumor-on-a-chip
Liver Tumor-on-a-chip
Organ Tumor Chip Segment by Application
Hospital
Laboratory
Organ Tumor Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Tumor Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Tumor Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Tumor Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Organ Tumor Chip production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Organ Tumor Chip in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Organ Tumor Chip manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organ Tumor Chip sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Tumor-on-a-chip
- Bone Marrow Tumor-on-a-chip
- Brain Tumor-on-a-chip
- Breast Tumor-on-a-chip
- Urinary System Tumor-on-a-chip
- Intestine Tumor-on-a-chip
- Liver Tumor-on-a-chip
Applications
- Hospital
- Laboratory
Companies covered
- Axosim Technologies
- Beonchip
- BioIVT
- Emulate
- InSphero AG
- Mimetas
- Nortis
- Organovo Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Organ Tumor Chip Market by Type
- 1.2.1 Global Organ Tumor Chip Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Lung Tumor-on-a-chip
- 1.2.3 Bone Marrow Tumor-on-a-chip
- 1.2.4 Brain Tumor-on-a-chip
- 1.2.5 Breast Tumor-on-a-chip
- 1.2.6 Urinary System Tumor-on-a-chip
- 1.2.7 Intestine Tumor-on-a-chip
- 1.2.8 Liver Tumor-on-a-chip
- 1.3 Organ Tumor Chip Market by Application
- 1.3.1 Global Organ Tumor Chip Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Laboratory
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Organ Tumor Chip Market Dynamics
- 2.1 Organ Tumor Chip Industry Trends
- 2.2 Organ Tumor Chip Industry Drivers
- 2.3 Organ Tumor Chip Industry Opportunities and Challenges
- 2.4 Organ Tumor Chip Industry Restraints
3 Global Organ Tumor Chip Production Overview
- 3.1 Global Organ Tumor Chip Production Capacity (2021-2032)
- 3.2 Global Organ Tumor Chip Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Organ Tumor Chip Production by Region
- 3.3.1 Global Organ Tumor Chip Production by Region (2021-2026)
- 3.3.2 Global Organ Tumor Chip Production by Region (2027-2032)
- 3.3.3 Global Organ Tumor Chip Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
- 3.8 South Korea
4 Global Market Growth Prospects
- 4.1 Global Organ Tumor Chip Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Organ Tumor Chip Revenue by Region
- 4.2.1 Global Organ Tumor Chip Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Organ Tumor Chip Revenue by Region (2021-2026)
- 4.2.3 Global Organ Tumor Chip Revenue by Region (2027-2032)
- 4.2.4 Global Organ Tumor Chip Revenue Market Share by Region (2021-2032)
- 4.3 Global Organ Tumor Chip Sales Estimates and Forecasts 2021-2032
- 4.4 Global Organ Tumor Chip Sales by Region
- 4.4.1 Global Organ Tumor Chip Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Organ Tumor Chip Sales by Region (2021-2026)
- 4.4.3 Global Organ Tumor Chip Sales by Region (2027-2032)
- 4.4.4 Global Organ Tumor Chip Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Organ Tumor Chip Revenue by Manufacturers
- 5.1.1 Global Organ Tumor Chip Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Organ Tumor Chip Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Organ Tumor Chip Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Organ Tumor Chip Sales by Manufacturers
- 5.2.1 Global Organ Tumor Chip Sales by Manufacturers (2021-2026)
- 5.2.2 Global Organ Tumor Chip Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Organ Tumor Chip Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Organ Tumor Chip Sales Price by Manufacturers (2021-2026)
- 5.4 Global Organ Tumor Chip Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Organ Tumor Chip Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Organ Tumor Chip Manufacturers, Product Type & Application
- 5.7 Global Organ Tumor Chip Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Organ Tumor Chip Market CR5 and HHI
- 5.8.2 2025 Organ Tumor Chip Tier 1, Tier 2, and Tier 3
6 Organ Tumor Chip Market by Type
- 6.1 Global Organ Tumor Chip Revenue by Type
- 6.1.1 Global Organ Tumor Chip Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Organ Tumor Chip Revenue Market Share by Type (2021-2032)
- 6.2 Global Organ Tumor Chip Sales by Type
- 6.2.1 Global Organ Tumor Chip Sales by Type (2021-2032) & (k units)
- 6.2.2 Global Organ Tumor Chip Sales Market Share by Type (2021-2032)
- 6.3 Global Organ Tumor Chip Price by Type
7 Organ Tumor Chip Market by Application
- 7.1 Global Organ Tumor Chip Revenue by Application
- 7.1.1 Global Organ Tumor Chip Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Organ Tumor Chip Revenue Market Share by Application (2021-2032)
- 7.2 Global Organ Tumor Chip Sales by Application
- 7.2.1 Global Organ Tumor Chip Sales by Application (2021-2032) & (k units)
- 7.2.2 Global Organ Tumor Chip Sales Market Share by Application (2021-2032)
- 7.3 Global Organ Tumor Chip Price by Application
8 Company Profiles
- 8.1 Axosim Technologies
- 8.1.1 Axosim Technologies Company Information
- 8.1.2 Axosim Technologies Business Overview
- 8.1.3 Axosim Technologies Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Axosim Technologies Organ Tumor Chip Product Portfolio
- 8.1.5 Axosim Technologies Recent Developments
- 8.2 Beonchip
- 8.2.1 Beonchip Company Information
- 8.2.2 Beonchip Business Overview
- 8.2.3 Beonchip Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Beonchip Organ Tumor Chip Product Portfolio
- 8.2.5 Beonchip Recent Developments
- 8.3 BioIVT
- 8.3.1 BioIVT Company Information
- 8.3.2 BioIVT Business Overview
- 8.3.3 BioIVT Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 BioIVT Organ Tumor Chip Product Portfolio
- 8.3.5 BioIVT Recent Developments
- 8.4 Emulate
- 8.4.1 Emulate Company Information
- 8.4.2 Emulate Business Overview
- 8.4.3 Emulate Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Emulate Organ Tumor Chip Product Portfolio
- 8.4.5 Emulate Recent Developments
- 8.5 InSphero AG
- 8.5.1 InSphero AG Company Information
- 8.5.2 InSphero AG Business Overview
- 8.5.3 InSphero AG Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 InSphero AG Organ Tumor Chip Product Portfolio
- 8.5.5 InSphero AG Recent Developments
- 8.6 Mimetas
- 8.6.1 Mimetas Company Information
- 8.6.2 Mimetas Business Overview
- 8.6.3 Mimetas Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Mimetas Organ Tumor Chip Product Portfolio
- 8.6.5 Mimetas Recent Developments
- 8.7 Nortis
- 8.7.1 Nortis Company Information
- 8.7.2 Nortis Business Overview
- 8.7.3 Nortis Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Nortis Organ Tumor Chip Product Portfolio
- 8.7.5 Nortis Recent Developments
- 8.8 Organovo Holdings
- 8.8.1 Organovo Holdings Company Information
- 8.8.2 Organovo Holdings Business Overview
- 8.8.3 Organovo Holdings Organ Tumor Chip Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.8.4 Organovo Holdings Organ Tumor Chip Product Portfolio
- 8.8.5 Organovo Holdings Recent Developments
9 North America
- 9.1 North America Organ Tumor Chip Market Size by Type
- 9.1.1 North America Organ Tumor Chip Revenue by Type (2021-2032)
- 9.1.2 North America Organ Tumor Chip Sales by Type (2021-2032)
- 9.1.3 North America Organ Tumor Chip Price by Type (2021-2032)
- 9.2 North America Organ Tumor Chip Market Size by Application
- 9.2.1 North America Organ Tumor Chip Revenue by Application (2021-2032)
- 9.2.2 North America Organ Tumor Chip Sales by Application (2021-2032)
- 9.2.3 North America Organ Tumor Chip Price by Application (2021-2032)
- 9.3 North America Organ Tumor Chip Market Size by Country
- 9.3.1 North America Organ Tumor Chip Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Organ Tumor Chip Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Organ Tumor Chip Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Organ Tumor Chip Market Size by Type
- 10.1.1 Europe Organ Tumor Chip Revenue by Type (2021-2032)
- 10.1.2 Europe Organ Tumor Chip Sales by Type (2021-2032)
- 10.1.3 Europe Organ Tumor Chip Price by Type (2021-2032)
- 10.2 Europe Organ Tumor Chip Market Size by Application
- 10.2.1 Europe Organ Tumor Chip Revenue by Application (2021-2032)
- 10.2.2 Europe Organ Tumor Chip Sales by Application (2021-2032)
- 10.2.3 Europe Organ Tumor Chip Price by Application (2021-2032)
- 10.3 Europe Organ Tumor Chip Market Size by Country
- 10.3.1 Europe Organ Tumor Chip Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Organ Tumor Chip Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Organ Tumor Chip Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Organ Tumor Chip Market Size by Type
- 11.1.1 China Organ Tumor Chip Revenue by Type (2021-2032)
- 11.1.2 China Organ Tumor Chip Sales by Type (2021-2032)
- 11.1.3 China Organ Tumor Chip Price by Type (2021-2032)
- 11.2 China Organ Tumor Chip Market Size by Application
- 11.2.1 China Organ Tumor Chip Revenue by Application (2021-2032)
- 11.2.2 China Organ Tumor Chip Sales by Application (2021-2032)
- 11.2.3 China Organ Tumor Chip Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Organ Tumor Chip Market Size by Type
- 12.1.1 Asia Organ Tumor Chip Revenue by Type (2021-2032)
- 12.1.2 Asia Organ Tumor Chip Sales by Type (2021-2032)
- 12.1.3 Asia Organ Tumor Chip Price by Type (2021-2032)
- 12.2 Asia Organ Tumor Chip Market Size by Application
- 12.2.1 Asia Organ Tumor Chip Revenue by Application (2021-2032)
- 12.2.2 Asia Organ Tumor Chip Sales by Application (2021-2032)
- 12.2.3 Asia Organ Tumor Chip Price by Application (2021-2032)
- 12.3 Asia Organ Tumor Chip Market Size by Country
- 12.3.1 Asia Organ Tumor Chip Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Organ Tumor Chip Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Organ Tumor Chip Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Organ Tumor Chip Market Size by Type
- 13.1.1 SAMEA Organ Tumor Chip Revenue by Type (2021-2032)
- 13.1.2 SAMEA Organ Tumor Chip Sales by Type (2021-2032)
- 13.1.3 SAMEA Organ Tumor Chip Price by Type (2021-2032)
- 13.2 SAMEA Organ Tumor Chip Market Size by Application
- 13.2.1 SAMEA Organ Tumor Chip Revenue by Application (2021-2032)
- 13.2.2 SAMEA Organ Tumor Chip Sales by Application (2021-2032)
- 13.2.3 SAMEA Organ Tumor Chip Price by Application (2021-2032)
- 13.3 SAMEA Organ Tumor Chip Market Size by Country
- 13.3.1 SAMEA Organ Tumor Chip Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Organ Tumor Chip Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Organ Tumor Chip Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Organ Tumor Chip Value Chain Analysis
- 14.1.1 Organ Tumor Chip Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Organ Tumor Chip Production Mode & Process
- 14.2 Organ Tumor Chip Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Organ Tumor Chip Distributors
- 14.2.3 Organ Tumor Chip Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst